Brenda Cooper
Clinical Program Director, UH Cleveland Medical Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
Credentials: · · · ·
History
PresentClinical, UH Cleveland Medical Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
- 1990–1992
Fellowship | Medical Oncology
- 1980–1984
1976–1980
Research
Journal of Clinical Oncology · 2000 · 846 citations
Biology of Blood and Marrow Transplantation · 2005 · 622 citations
Blood · 1993 · 463 citations
67 papers
35 papers
31 papers
26 papers
21 papers · 1 as a fellow
19 papers
16 papers
16 papers · 1 as a fellow
Grants
- 1997–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $105.8K · Case Western Reserve University
- 1999–2002
Mechanism Based Phase i Trial of Topotecan in Leukemia
National Cancer Institute · R21
Contact PI · $306K · Case Western Reserve University
Clinical trials
- 2021–2025
Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT
Principal investigator · Completed
Case Comprehensive Cancer Center
- 2010–2012
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Principal investigator · Completed · Phase 1, Phase 2
Case Comprehensive Cancer Center
- 2009–2017
Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Principal investigator · Completed · Phase 1, Phase 2
Brenda Cooper, MD
- 2008–2015
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center